… than ever before for people living with the disease. Tune into audio from this Third Thursdays Webinar to hear movement … experts and a person living with Parkinson’s answer community questions about the new treatments available, explain how therapies make it through FDA approval and share the …

… For many, the holidays are a joyful time to gather with loved ones and friends, reflect on the past year and think about what’s to come. But for some with recently diagnosed or progressing … gatherings. Tell a loved one what you’re experiencing and how they can help: by listening, checking in with you …

… onset age. This observation raises the suspicion that factors other than genetic determinants based on inherited DNA … Contursi kindred and assess the correlation between this outcome measure and age at symptom onset. If a correlation is … her hypothesis. Preliminary data supported by this award showed that this gene is methylated at specific sites. It …

… This is the family forest.  It’s time the Baby Boomers come out and wreck Old Age like we wrecked the universities, … a fight. Such as the perfectly normal request that Pharma stop throwing clinical trials into the shredder if the … like Parkies talk to each other, but not to anybody else. How can it be that half the studies get thrown off the boat, …

… A compound that researchers believe may lower the risk of … with Parkinson's within the last three years. SURE-PD3 aims to enroll 270 people across 60 U.S. clinical sites for the … on Fox Trial Finder . Earlier observational studies showed that individuals with higher levels of the antioxidant …

… by prescription. Read more below, talk with your doctor and visit the Ongentys website to learn more about this … The new medication, a catechol-O-methyltransferase (COMT) inhibitor, prevents levodopa breakdown so that more … is the “best” drug. For more on what to think about and how to talk to your doctor about newly approved medications, …